BTX
FINANCIAL SERVICESBlackRock Innovation and Growth Term Trust
$8.18+0.04 (+0.49%)PRE
Live · NYSE · May 9, Close
AI Insight
What's Moving BTX Today?
No stock-specific AI insight has been generated for BTX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$5.79$8.22
$8.18
Fundamentals
Market Cap$955M
P/E Ratio22.1
EPS$0.37
Dividend Yield—
Dividend / Share—
ROE-4.3%
Profit Margin—
Debt / Equity—
Trading
Volume607K
Avg Volume (10D)—
Shares Outstanding116.7M
BTX News
11 articles- Certain BlackRock Closed-End Funds Announce Estimated Sources of DistributionsYahoo Finance·Apr 30, 2026
- We Think That There Are Some Issues For Anchun International Holdings (SGX:BTX) Beyond Its Promising EarningsYahoo Finance·Apr 14, 2026
- Jim Cramer on Tower Semiconductor (TSEM): “I Would Take a Little Off Just Because It’s Had, It’s Had a Parabolic Move in the Last Few Weeks”Yahoo Finance·Mar 28, 2026
- Via Transportation (VIA) Slid Due to Broadening of LossesYahoo Finance·Feb 13, 2026
- Ciena Corporation’s (CIEN) Underweight Position Hurt BTX’s PerformanceYahoo Finance·Feb 13, 2026
- BTX Benefited from an Overweight Position in Tower Semiconductor (TSEM)Yahoo Finance·Feb 13, 2026
- Strong Earnings Momentum and Investor Optimism Lifted Lumentum Holdings (LITE) in Q4Yahoo Finance·Feb 13, 2026
- BlackRock Announces Update to BMEZ, BSTZ, and BTX Managed Distribution PlansYahoo Finance·Sep 11, 2025
- BlackRock Technology and Private Equity Term Trust (BTX) Announces Final Results of Tender OfferYahoo Finance·Jul 10, 2025
- BlackRock Technology and Private Equity Term Trust (BTX) Announces Expiration and Preliminary Results of Tender OfferYahoo Finance·Jul 9, 2025
- BlackRock Technology and Private Equity Term Trust (BTX) Commences Tender Offer for up to 50% of outstanding common sharesYahoo Finance·Jun 9, 2025
All 11 articles loaded
Price Data
Open$8.08
Previous Close$8.14
Day High$8.16
Day Low$8.08
52 Week High$8.22
52 Week Low$5.79
52-Week Range
$5.79$8.22
$8.18
Fundamentals
Market Cap$955M
P/E Ratio22.1
EPS$0.37
Dividend Yield—
Dividend / Share—
ROE-4.3%
Profit Margin—
Debt / Equity—
Trading
Volume607K
Avg Volume (10D)—
Shares Outstanding116.7M
About BlackRock Innovation and Growth Term Trust
Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. The company is headquartered in Brooklyn, New York.
Listed March 26, 2021
FINANCIAL SERVICESASSET MANAGEMENT
Company Details
Security TypeStock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICASSET MANAGEMENT
CIK—
Composite FIGI—
Share Class FIGI—